Aligos Therapeutics (ALGS)

• Market cap: $43.6M
• 1 day: 2.16%
• 5 days: 7.59%
• 1 month: -15.49%
• 3 months: -25.53%
• 6 months: -30.56%
• Year to date: -22.34%
• 1 year: -60.21%
• 5 years: -98.9%
• 10 years: -98.09%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70